UPL rises as brokerage backs Superform growth outlook
In short
UPL shares rose 5% after a brokerage said Superform is aiming for 20% to 23% annual revenue growth. The report said phosphorus and cyanide chemistries are expected to drive that growth.
This matters because investors are reacting to the business outlook for UPL’s speciality chemicals arm. It is still not clear whether the targets are official company guidance.
What the reporting says
UPL shares jumped after a brokerage said Superform is targeting annual revenue growth of 20% to 23%, with phosphorus and cyanide chemistries seen as key drivers. The reporting does not say that these targets were company guidance or that the forecast was revised. The immediate market effect was a share-price reaction tied to the speciality chemicals outlook.
Why it matters
UPL shares moved higher after a brokerage said Superform is targeting 20% to 23% annual revenue growth, with phosphorus and cyanide chemistries flagged as growth drivers. The reporting does not state whether this is management guidance or a brokerage projection. The move matters for UPL shareholders and broader India markets watching speciality chemicals sentiment.